Pneumococcus infections: Is the burden still as heavy?

Medecine et Maladies Infectieuses

Volumn 42, Issue 4, 2012, Pages 149-153

  Chavanet, P ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Pneumococcal invasive infections; Serotypes; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ALCOHOL ABUSE; ANTIBIOTIC THERAPY; DEVELOPING COUNTRY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; INFECTION RISK; LUNG DISEASE; MORTALITY; PNEUMOCOCCAL INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SEROTYPING; SOLID TUMOR; VACCINATION;

ADULT; AGE FACTORS; CHILD; DEVELOPED COUNTRIES; DISEASE SUSCEPTIBILITY; FRANCE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; WORLD HEALTH;

EID: 84861182001     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.02.002     Document Type: Review

References (45)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
2. Ausubel J., Meyer P., Wernick I. Death and the human environment: the United States in the 20th Century. Technology in Society 2001, 23:131-146.
3. Osler W. The principles and practice of medicine 1892, D Appleton & Co, New York. 1st Ed.
4. Mulholland K. Perspectives on the burden of pneumonia in children. Vaccine 2007, 25:2394-2397.
5. Feikin D.R., Klugman K.P. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 2002, 35:547-555.
6. Trzcinski K., Thompson C.M., Gilbey A.M., Dowson C.G., Lipsitch M. Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis 2006, 193:1296-1303.
7. Chien Y., Klugman K., Morens D. Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. J Infect Dis 2010, 202:1639-1648.
8. Harboe Z.B., Benfield T.L., Valentiner-Branth P., Hjuler T., Lambertsen L., Kaltoft M., et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 2010, 50:329-337.
9. Fenoll A., Granizo J.J., Aguilar L., Giménez M.J., Aragoneses-Fenoll L., Hanquet G., et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 2009, 47:1012-1020.
10. Trampuz A., Widmer A.F., Fluckiger U., Haenggi M., Frei R., Zimmerli W. Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986-2000. Mayo Clin Proc 2004, 79:604-612.
11. Harboe Z.B., Thomsen R.W., Riis A., Valentiner-Branth P., Christensen J.J., Lambertsen L., et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009, 6:e1000081.
12. Weinberger D.M., Harboe Z.B., Sanders E.A., Ndiritu M., Klugman K.P., Rückinger S., et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010, 51:692-699.
13. Azoulay-Dupuis E., Rieux V., Muffat-Joly M., Bédos J.P., Vallée E., Rivier C., et al. Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother 2000, 44:1575-1577.
14. Finland M., Barnes M.W. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol 1977, 5:154-166.
15. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201:32-41.
16. Dorléans F, Varon E, Lepoutre A, Georges S, Gutmann L, Lévy-Bruhl D, et al. Impact de la vaccination par le vaccin pneumococcal conjugué heptavalent sur l'incidence des invasive pneumococcal infections en France. Analyse des données de 2008; . http://www.invs.sante.fr/presse/2010/the_point_sur/vaccination_pneumo_050710/index.html%202010.
17. Walter N.D., Taylor T.H., Dowell S.F., Mathis S., Moore M.R. Holiday spikes in pneumococcal disease among older adults. N Engl J Med 2009, 361:2584-2585.
18. Fisman D.N., Abrutyn E., Spaude K.A., Kim A., Kirchner C., Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006, 42:1093-1101.
19. Armstrong G.L., Conn T.H.E., Pinner R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281:61-66.
20. Martens P., Worm S.W., Lundgren B., Konradsen H.B., Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004, 4:21.
21. Jansen A.G., Rodenburg G.D., van der Ende A., van Alphen L., Veenhoven R.H., Spanjaard L., et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009, 49:e23-e29.
22. Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 2008; 13: pii 18962.
23. Varon E. Epidémiologie des infections à pneumocoque 2010, Centre national de référence du pneumocoque, Paris.
24. Bourneton O., Mutel T., Heranney D., Hernandez C., Lavigne T., Waller J., et al. Incidence of hospital-acquired and community-acquired bloodstream infections in the University of Strasbourg Hospitals France, between 2005 and 2007. Pathol Biol (Paris) 2010, 58:29-34.
25. Réseau EPIBAC . http://www.invs.sante.fr/surveillance/epibac/donnees.htm.
26. Kyaw M.H., Christie P., Clarke S.C., Mooney J.D., Ahmed S., Jones I.G., et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 2003, 37:1283-1291.
27. Grijalva C.G., Nuorti J.P., Zhu Y., Griffin M.R. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 2010, 50:805-813.
28. Byington C.L., Hulten K.G., Ampofo K., Sheng X., Pavia A.T., Blaschke A.J., et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010, 48:520-525.
29. Kyaw M.H., Rose C.E., Fry A.M., Singleton J.A., Moore Z., Zell E.R., et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005, 192:377-386.
30. Benard A., Mercie P., Alioum A., Bonnet F., Lazaro E., Dupon M., et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation, ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS One 2010, 5:e8896.
31. Hsu K.K., Shea K.M., Stevenson A.E., Pelton S.I. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J 2010, 29:289-293.
32. Cohen R., Levy C., Bonnet E., Grondin S., Desvignes V., Lecuyer A., et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28:6114-6121.
33. Munoz-Almagro C., Jordan I., Gene A., Latorre C., Garcia-Garcia J.J., Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46:174-182.
34. Chavanet P., Atal A., Mahy S., Neuwirth C., Dabernat H., Portier H. Portage nasopharyngé, sensibilités et sérotypes de Streptococcus pneumoniae et Haemophilus influenzae chez les children de crèches de Dijon, Bourgogne (France). Med Mal Infect 2011, 41:307-317.
35. Yildigrim I., Hanage W., Lipsitch M., Shea K.M., Stevenson A., Finkelstein J., et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010, 29(2):283-288. Epub 2010 Oct 26.
36. Melegaro A., Choi Y.H., George R., Edmunds W.J., Miller E., Gay N.J. Dynamic models of pneumococcal carriage and the impact of the heptavalent pneumococcal conjugate vaccine on invasive pneumococcal disease. BMC Infect Dis 2010, 10:90.
37. Isaacman D.J., McIntosh E.D., Reinert R.R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010, 14:e197-e209.
38. Laupland K.B., Gregson D.B., Zygun D.A., Doig C.J., Mortis G., Church D.L. Severe bloodstream infections: a population-based assessment. Crit Care Med 2004, 32:992-997.
39. Laupland K.B., Gregson D.B., Vanderkooi O.G., Ross T., Kellner J.D. The changing burden of pediatric bloodstream infections in Calgary Canada, 2000-2006. Pediatr Infect Dis J 2009, 28:114-117.
40. Laupland K.B., Gregson D.B., Flemons W.W., Hawkins D., Ross T., Church D.L. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect 2007, 135:1037-1042.
41. Haut conseil de the santé publique The Calendrier des vaccinations et les recommandations vaccinales 2010. Bulletin Epidémiologique Hebdomadaire 2010, p. 14-5.
42. American Academy of Pediatrics Committee on Infectious Diseases Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics 2010, 126:186-190.
43. Holt L. The Principles and Practice of Medicine. 1903, D. Appleton & Co, New York. W. Osler (Ed.).
44. Kohn J., Weiner S. Pneumonia in children: a survey of one thousand cases with attempted follow-up. Am J Dis Child 1936, 51:1095-1100.
45. Klemets P., Lyytikainen O., Ruutu P., Ollgren J., Pekka Nuorti J. Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies. BMC Infect Dis 2008, 8:96.